C58939 |
Additional agents administered type |
Type of specific additional agent administered for an infection.
|
Supplemental |
1.00 |
2019-01-03 15:21:49.0 |
Infection Form - Adapted from BMTCTN 15070 |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60500 |
Evidence polyclonal gene-modified hematopoiesis specimen type |
Type of specimen in which evidence was found of polyclonal gene-modified hematopoiesis.
|
Supplemental |
1.00 |
2021-04-22 14:23:03.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C15585 |
Imaging stimulation type |
Type of stimulation
|
Supplemental ? Highly Recommended |
3.00 |
2013-07-16 14:01:43.01 |
Functional Magnetic Resonance Imaging (fMRI) |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60404 |
Imaging MRI strength pulse sequence type |
Type of strength and pulse sequence used in the magnetic resonance imaging (MRI) device.
|
Supplemental |
1.00 |
2021-04-07 16:15:26.0 |
Silent Cerebral Infarct |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59422 |
Child stroke rehabilitation treatment current type |
Type of stroke rehabilitation treatment the respondent's child is currently receiving
|
Proposed |
1.00 |
2019-04-04 11:10:44.0 |
PhenX Toolkit: Neurology, QOL Health Services Recovery and Recurrence Questionnaire - Pediatric |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60496 |
Vector integration site analysis substrate type |
Type of substrate(s) on which Vector Integration Site Analysis (VISA) was performed.
|
Supplemental |
1.00 |
2021-04-22 14:01:20.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C54094 |
Test assessment type |
Type of test procedure or assessment administered
|
Supplemental |
1.00 |
2017-02-13 00:00:00.0 |
Trail Making Test (TMT), Delis-Kaplan Executive Function System (D-KEFS) |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60130 |
Spleen function test type |
Type of test(s) performed to assess function of the spleen.
|
Supplemental |
1.00 |
2021-01-15 10:54:31.0 |
Acute Spleen |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59402 |
Child stroke any subsequent clot type |
Type of the respondent's child's blood clot at any anatomic site, if any, since his or her initial stroke
|
Proposed |
1.00 |
2019-04-03 11:54:17.0 |
PhenX Toolkit: Neurology, QOL Health Services Recovery and Recurrence Questionnaire - Pediatric |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60148 |
Blood ABO type |
Type of the subject/participant's blood using the ABO and Rh factor designations.
|
Core |
1.00 |
2021-01-19 08:30:43.0 |
Laboratory Tests |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60635 |
Tissue monitoring type |
Type of tissue sampled for monitoring
|
Core |
1.00 |
2021-04-29 16:24:47.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C00719 |
Tobacco product used type |
Type of tobacco product (e.g., cigarettes, cigars, chewing tobacco or pipe) used by the participant/subject
|
Core |
3.00 |
2013-07-20 10:21:25.65 |
Behavioral History |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C05148 |
Transfusion type |
Type of transfusion performed
|
Supplemental |
3.00 |
2013-07-20 10:21:25.65 |
Acute Chest Syndrome |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59420 |
Child stroke treatment current type |
Type of treatment for stroke that the respondent's child is currently taking
|
Proposed |
1.00 |
2019-04-03 15:46:06.0 |
PhenX Toolkit: Neurology, QOL Health Services Recovery and Recurrence Questionnaire - Pediatric |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C59411 |
Child stroke treatment initial type |
Type of treatment for stroke that the respondent's child was being given at the beginning of the stroke or clotting episode subsequent to his or her initial stroke
|
Proposed |
1.00 |
2019-04-03 15:46:06.0 |
PhenX Toolkit: Neurology, QOL Health Services Recovery and Recurrence Questionnaire - Pediatric |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60467 |
Abnormal hematopoiesis treatment type |
Type of treatment undertaken for abnormal hematopoiesis.
|
Supplemental |
1.00 |
2021-04-22 10:25:09.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C04515 |
ECG ventricular arrhythmia type |
Type of ventricular arrythmia, if any, apparent on the electrocardiogram (EKG) being reported
|
Supplemental |
3.00 |
2013-07-25 08:54:08.2 |
Electrocardiogram (ECG) |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60468 |
Transfusion blood product type |
Type(s) of blood product(s) introduced as part of transfusion.
|
Supplemental |
1.00 |
2021-04-22 10:29:39.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60063 |
Clinical features present type |
Type(s) of clinical features the subject/participant presented with.
|
Supplemental |
1.00 |
2020-09-03 14:36:31.0 |
Immune Function Form |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60461 |
Cytogenetic abnormality type |
Type(s) of cytogenic abnormalities identified in cytogenetics testing.
|
Supplemental |
1.00 |
2021-04-22 09:51:37.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60621 |
Drug illicit use type |
Type(s) of illicit drugs used by the subject/participant
|
Supplemental - Highly Recommended |
1.00 |
2021-04-29 14:17:31.0 |
Behavioral History Short Form |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60609 |
Priapism intervention type |
Type(s) of interventions provided to the subject/participant for his priapism.
|
Core |
1.00 |
2021-04-29 13:31:43.0 |
Priapism Core |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60612 |
Priapism prevention medication prescribe type |
Type(s) of medications prescribed for the prevention of priapism.
|
Core |
1.00 |
2021-04-29 13:41:40.0 |
Priapism Core |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60575 |
Alloantibody red blood cell type |
Type(s) of red blood cell (RBC) alloantibodies identified in the subject/participant.
|
Core |
1.00 |
2021-04-28 14:19:50.0 |
Transfusion History |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C00215 |
Living with person relationship type |
Type(s) of relationship(s) that obtain between the participant/subject and all people with whom she or he currently lives, cohabits, or stays
|
Supplemental |
3.00 |
2013-07-25 08:54:08.2 |
Social Status |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|